4.4 Review

The use of non-tumor data in cancer risk assessment: reflections on butadiene, vinyl chloride, and benzene

Journal

REGULATORY TOXICOLOGY AND PHARMACOLOGY
Volume 37, Issue 1, Pages 105-132

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/S0273-2300(02)00019-3

Keywords

cancer; risk assessment; biomarkers; 1,3-butadiene; benzene; vinyl chloride; principles

Funding

  1. NCI NIH HHS [P30-CA16086] Funding Source: Medline
  2. NIEHS NIH HHS [P30ES01896, P42ES05948, ES07126, P30-ES10126, ES11746, R01ES06721, P42 ES004705, P42ES04705] Funding Source: Medline

Ask authors/readers for more resources

The estimation and characterization of a cancer risk is grounded in the observation of tumors in humans and/or experimental animals. Increasingly, however, other kinds of data (non-tumor data) are finding application in cancer risk assessment. Metabolism and kinetics, adduct formation, genetic damage, mode of action, and biomarkers of exposure, susceptibility, and effects are examples. While these and other parameters have been studied for many important chemicals over the past 30-40 years, their use in risk assessments is more recent, and new insights and opportunities are continuing to unfold. To provide some perspective on this field, the ILSI Risk Science Institute asked a select working group to characterize the pertinent non-tumor data available for 1,3-butadiene, benzene, and vinyl chloride and to comment on the utility of these data in characterizing cancer risks. This paper presents the findings of that working group and concludes with 15 simple principles for the use of non-tumor data in cancer risk assessment. (C) 2003 Elsevier Science (USA). All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available